Patent Number: 8,796,253

Title: Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

Abstract: This invention relates to novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients or therapeutic measures.

Inventors: Boyer; Stephen (Bethany, CT), Harter; Michael (Leverkusen, DE), Wickens; Philip (Richmond Hill, CA), Patel; Manoj (Berlin, CT), Kumarasinghe; Ellalahewage Sathyajith (Franklin, MA), Bhargava; Ajay Kumar (Woodbridge, CT), Thierauch; Karl-Heinz (Berlin, DE), Beck; Hartmut (Koln, DE), Greschat; Susanne (Dusseldorf, DE), Ellinghaus; Peter (Melle, DE), Paulus; Patrick (Frankfurt am Main, DE), Hess-Stumpp; Holger (Berlin, DE)

Assignee: Bayer Intellectual Property GmbH

International Classification: C07D 403/04 (20060101); C07D 413/04 (20060101); C07D 413/14 (20060101); C07D 471/04 (20060101); C07D 491/04 (20060101)

Expiration Date: 8/05/12018